glp 1 pathophysiology Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism Glucagon-like peptide-1 receptor: mechanisms and

Biochimie , 165 , 250-257

In conclusion, our results indicate that GLP-1 analogs have significant anti-obesity effects in MC4R and POMC pathway-deficient models, providing evidence of their potential effectiveness in patients with these rare genetic conditions

Females of Reproductive Potential and Males There is no FDA guidance on the use of Levocarnitine (injection) in women of reproductive potentials and males

GLP-1 receptor agonists and surgical care: implications for bariatric procedures, perioperative outcomes, and nutritional optimization

Obesity 32(1):5058 Colbourne JR et al (2023) The role of adjuvant pharmacotherapy with liraglutide for patients with inadequate weight loss following bariatric surgery